FDA Approves AbbVie’s Vuity as the First Eyedrop for Presbyopia
XTalks
NOVEMBER 4, 2021
Related: Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer. The FDA approval of Vuity exemplifies our continued pursuit of innovative new treatments that push the boundaries of what’s possible in eye care.”. Vuity is available by prescription.
Let's personalize your content